Allstate (NYSE:ALL - Get Free Report)'s stock had its "strong-buy" rating reiterated by Raymond James Financial in a report issued on Monday,Benzinga reports. They currently have a $260.00 target price on the insurance provider's stock, up from their prior target price of $250.00. Raymond James Financial's target price indicates a potential upside of 28.64% from the stock's previous close.
A number of other equities research analysts have also issued reports on the company. Morgan Stanley upped their price target on Allstate from $235.00 to $245.00 and gave the company an "overweight" rating in a research report on Friday. Evercore ISI raised their target price on Allstate from $227.00 to $230.00 and gave the stock an "outperform" rating in a research note on Thursday, May 1st. UBS Group boosted their price target on shares of Allstate from $230.00 to $235.00 and gave the company a "buy" rating in a research report on Wednesday, July 9th. Wells Fargo & Company reduced their target price on shares of Allstate from $200.00 to $197.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Allstate from $217.00 to $222.00 and gave the company an "overweight" rating in a research report on Tuesday, April 8th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $229.07.
Read Our Latest Research Report on ALL
Allstate Price Performance
Shares of Allstate stock traded up $2.34 on Monday, hitting $202.11. The company's stock had a trading volume of 217,817 shares, compared to its average volume of 1,768,076. The company has a market capitalization of $53.26 billion, a price-to-earnings ratio of 9.50, a price-to-earnings-growth ratio of 0.90 and a beta of 0.35. The firm has a fifty day moving average price of $198.37 and a 200-day moving average price of $197.31. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.43 and a current ratio of 0.43. Allstate has a 1 year low of $168.36 and a 1 year high of $213.18.
Allstate (NYSE:ALL - Get Free Report) last released its earnings results on Wednesday, July 30th. The insurance provider reported $5.94 EPS for the quarter, topping analysts' consensus estimates of $3.20 by $2.74. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The business had revenue of $15.05 billion during the quarter, compared to analysts' expectations of $16.59 billion. During the same quarter in the previous year, the company earned $1.61 earnings per share. The company's quarterly revenue was up 5.8% on a year-over-year basis. As a group, sell-side analysts anticipate that Allstate will post 18.74 earnings per share for the current fiscal year.
Institutional Trading of Allstate
A number of institutional investors have recently added to or reduced their stakes in ALL. Sequoia Financial Advisors LLC grew its position in shares of Allstate by 30.3% in the first quarter. Sequoia Financial Advisors LLC now owns 11,361 shares of the insurance provider's stock valued at $2,352,000 after purchasing an additional 2,643 shares during the last quarter. Richard Bernstein Advisors LLC acquired a new stake in Allstate during the 1st quarter valued at $3,341,000. Dock Street Asset Management Inc. acquired a new stake in Allstate during the 1st quarter valued at $207,000. First Citizens Bank & Trust Co. increased its position in Allstate by 5.5% during the first quarter. First Citizens Bank & Trust Co. now owns 57,499 shares of the insurance provider's stock worth $11,906,000 after buying an additional 2,981 shares in the last quarter. Finally, Blackstone Inc. acquired a new position in shares of Allstate in the fourth quarter worth $52,053,000. Hedge funds and other institutional investors own 76.47% of the company's stock.
About Allstate
(
Get Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.